Anti-ITA4/ ITGA4/ CD49D monoclonal antibody
Anti-ITA4/ ITGA4/ CD49D antibody for FACS & in-vivo assay
Go to ITGA4/ITGA4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T97587-Ab-1/ GM-Tg-hg-T97587-Ab-2 | Anti-Human ITGA4 monoclonal antibody | Human |
GM-Tg-rg-T97587-Ab-1/ GM-Tg-rg-T97587-Ab-2 | Anti-Rat ITGA4 monoclonal antibody | Rat |
GM-Tg-mg-T97587-Ab-1/ GM-Tg-mg-T97587-Ab-2 | Anti-Mouse ITGA4 monoclonal antibody | Mouse |
GM-Tg-cynog-T97587-Ab-1/ GM-Tg-cynog-T97587-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ITGA4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T97587-Ab-1/ GM-Tg-felg-T97587-Ab-2 | Anti-Feline ITGA4 monoclonal antibody | Feline |
GM-Tg-cang-T97587-Ab-1/ GM-Tg-cang-T97587-Ab-2 | Anti-Canine ITGA4 monoclonal antibody | Canine |
GM-Tg-bovg-T97587-Ab-1/ GM-Tg-bovg-T97587-Ab-2 | Anti-Bovine ITGA4 monoclonal antibody | Bovine |
GM-Tg-equg-T97587-Ab-1/ GM-Tg-equg-T97587-Ab-2 | Anti-Equine ITGA4 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T97587-Ab-1/ GM-Tg-hg-T97587-Ab-2; GM-Tg-rg-T97587-Ab-1/ GM-Tg-rg-T97587-Ab-2; GM-Tg-mg-T97587-Ab-1/ GM-Tg-mg-T97587-Ab-2; GM-Tg-cynog-T97587-Ab-1/ GM-Tg-cynog-T97587-Ab-2; GM-Tg-felg-T97587-Ab-1/ GM-Tg-felg-T97587-Ab-2; GM-Tg-cang-T97587-Ab-1/ GM-Tg-cang-T97587-Ab-2; GM-Tg-bovg-T97587-Ab-1/ GM-Tg-bovg-T97587-Ab-2; GM-Tg-equg-T97587-Ab-1/ GM-Tg-equg-T97587-Ab-2 |
Products Name | Anti-ITGA4 monoclonal antibody |
Format | mab |
Target Name | ITGA4 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ITGA4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Biosimilar | GMP-Bios-ab-616 | Pre-Made Vedolizumab biosimilar, Whole mAb, Anti-ITGA4;ITGB7 Antibody: Anti-CD49D/IA4 therapeutic antibody |
Biosimilar | GMP-Bios-ab-200 | Pre-Made Etrolizumab biosimilar, Whole Mab: Anti-ITGA4;ITGB7;ITGAE;ITGB7 therapeutic antibody |
Biosimilar | GMP-Bios-ab-005 | Pre-Made Abrilumab biosimilar, Whole mAb, Anti-α4β7/Integrin alpha 4 beta 7 Antibody: Anti-LPAM‑1 therapeutic antibody |
Biosimilar | GMP-Bios-ab-367 | Pre-Made Natalizumab biosimilar, Whole mAb, Anti-ITGA4 Antibody: Anti-CD49D/IA4 therapeutic antibody |
Target Antigen | Products Developing | Multi-species ITA4/ ITGA4/ CD49D VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-T97587 |
Target Name | ITGA4 |
Gene ID | 3676,16401,311144,704745,488429,101081745,282882,100067886 |
Gene Symbol and Synonyms | CD49D,IA4,ITGA4,Itga4B |
Uniprot Accession | P13612 |
Uniprot Entry Name | ITA4_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target, INN Index |
Disease | Cancer |
Gene Ensembl | ENSG00000115232 |
Target Classification | Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
The target: ITGA4, gene name: ITGA4, also named as CD49D, IA4. The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 4 subunit. This subunit associates with a beta 1 or beta 7 subunit to form an integrin that may play a role in cell motility and migration. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn's disease and inflammatory bowel disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.